Salimetrics Announces Changes to Increase Collaboration for Salivary Research

New ownership expands opportunities for developing salivary biomarkers for the research and diagnostic markets.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
We are in one of the most prolific periods of innovation and new products in Salimetrics’ history.

State College, PA (PRWEB) November 13, 2012

Salimetrics today announced ownership and executive management changes that will encourage greater collaboration between the Company’s world-class salivary assay teams and its research and diagnostic customers in order to further expand opportunities for developing new Salivary Biomarkers. As part of these changes, Hans Schroeder, Bob Larson, PhD, and Jon Peterson, PhD will add more responsibilities to their roles. Salimetrics also announced that co-founders Eve Schwartz and Richard Supina, who were integral in shepherding the company through its early start-up phase, have sold their shares in Salimetrics to Douglas Granger, PhD, founder, and Hans Schroeder, who will also serve as CEO. Dr. Granger, now a professor at Johns Hopkins University and the Director of the JHU Center for Interdisciplinary Salivary Bioscience Research, remains the Chief Scientific & Strategy Advisor and a majority owner of Salimetrics.

“We are in one of the most prolific periods of innovation and new products in Salimetrics’ history,” said Dr. Granger. “Salivary bioscience is at the dawn of a new age. The time is right and the time is now for salivary bioscience to make a difference in health and human development, and Salimetrics is an important part of the next chapter in this story. The tools we’ve introduced for saliva collection and testing could only have been created at Salimetrics and are the direct result of our relentless focus on tightly integrating world-class salivary assay teams and the salivary bioscience research community.” According to Mr. Schroeder, who joined Salimetrics in 2009, “This reorganization positions Salimetrics with a leadership team that has considerable experience in research and product development, a team that will responsibly guide the emergence of commercial and consumer applications derived from discoveries in the field of salivary bioscience.”

Bob Larson, PhD will take on the additional responsibility of site management, placing all of our State College, PA operations in one group. Jon Peterson, PhD will lead research and development for new salivary collection devices as well as salivary assays.

About Salimetrics:

Founded in 1998, Salimetrics, LLC supports researchers, the immunodiagnostic industry, and functional testing laboratories around the world with innovative salivary immunoassay products and services. Salimetrics’ assay kits and CLIA-certified testing services measure biomarkers related to stress, behavior and development, inflammation, and immune function, including: alpha-amylase, androstenedione, blood contamination, chromogranin A, cortisol, cotinine, C-reactive protein, DHEA, DHEA-S, estradiol, estriol, estrone, IL-1b, IL-6, melatonin, progesterone, 17α-hydroxyprogesterone, secretory IgA, testosterone, and TNF-a. Salimetrics also provides salivary DNA analysis. The company is based in State College, Pennsylvania, with offices in the UK and distributors around the world. For more information, visit Salimetrics on the web at http://www.salimetrics.com.


Contact